WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
- EBITDA, 2025
- $756M
- YoY, 2025
- +4.3%
- 5-year CAGR
- +8.1%
- 10-year CAGR
- +13.4%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $756M | +4.3% |
| 2024 | $725M | −10.4% |
| 2023 | $810M | −4.8% |
| 2022 | $851M | −2.1% |
| 2021 | $869M | +69.9% |
| 2020 | $512M | +29.0% |
| 2019 | $397M | +16.0% |
| 2018 | $342M | +6.8% |
| 2017 | $320M | +13.0% |
| 2016 | $283M | +32.0% |
| 2015 | $215M | −19.5% |
| 2014 | $267M | +9.6% |
| 2013 | $243M | +17.1% |
| 2012 | $208M | +15.1% |
| 2011 | $181M | +13.3% |
| 2010 | $160M | −1.2% |
| 2009 | $161M | −10.4% |
| 2008 | $180M | — |